FACT SHEET
Introducing GlucoseReady™: Transforming Cardiometabolic Trials
Download our fact sheet to learn more.
Introducing GlucoseReady™:
Transforming Cardiometabolic Clinical Trials
Experience the future of diabetes, obesity and NASH/MASH research with our integrated digital platform.
Key Features
Lifestyle & Behavioral Modification
Leveraging SPUR™ behavioral assessments and predictive analytics
Real-Time Data Capture
Meeting new FDA guidelines for seamless and immediate insights
Comprehensive eCOA Integration
From patient onboarding to in-clinic visits and reporting
Advanced Biomarker Analysis
Powered by Continuous
Glucose Monitoring (CGM) and Blood Glucose Meters (BGM)
Revolutionize Your Clinical Trials
with GlucoseReady™
with GlucoseReady™
GlucoseReady™ is a comprehensive solution designed to revolutionize cardiometabolic disease
clinical trials. Discover how our platform empowers researchers and enhances patient outcomes
through innovation and technology.
Improved Patient Engagement and Retention
Utilize the SPUR™ behavioral assessment tool and our predictive analytics to maintain patient engagement and minimize dropout rates. Our tools help understand and mitigate factors leading to non-compliance, ensuring a smoother, more efficient trial process.
Event-Driven Hypoglycemia ePRO
GlucoseReady™ will prompt the patient in real time to complete protocol-defined PRO questionnaires following a hypoglycemic event (CGM / BGM). These automatically triggered event questionnaires provide insights into the symptomatology of hypoglycemia as well as its causality.
Designed for Ease and Efficiency
GlucoseReady™ offers an intuitive user interface and seamless integration with existing clinical systems. This ease of use extends from the
lab to the field, enabling both researchers and participants
to interact with the platform effortlessly.
Immediate Insights with Near Real-Time Data
Leverage the power of CGM and BGM integrated into our platform to gain immediate insights into patient glucose levels. Near real-time data facilitates rapid decision-making and adaptation in trial protocols, aligning with the latest FDA guidance.
Discover more about GlucoseReady™
Deep Dive Into GlucoseReady™: Technology, Compliance and Advanced Data Integration and Reporting
GlucoseReady™ is not just advanced; it’s precision-engineered to meet new FDA guidance and the exacting standards of today’s cardiometabolic clinical trials.
Seamless Integration Across Systems
GlucoseReady™ excels in aggregating data from various sources including CGM, BGM, digital weight scales, and actigraphy devices. Our platform synthesizes this data within a cohesive framework, providing comprehensive analytics that support dynamic trial management and informed decision-making.
- Real-time data synthesis from multiple monitoring devices.
- Enhanced data accuracy through advanced algorithms.
- Support for adaptive clinical trial designs.
Exceeding Standards in Compliance and Security
Designed to meet the rigorous requirements of GCP and FDA guidelines, GlucoseReady™ ensures that all data handling processes uphold the highest standards of data security and patient privacy. Our platform is regularly updated to stay compliant with evolving regulations.
- Full compliance with FDA and GCP guidelines for clinical trials.
- Robust data encryption and secure user-authentication protocols.
- Regular audits and updates to ensure ongoing compliance.
Optimized for User Engagement and Support
Understanding that the user experience is critical, GlucoseReady™ features an intuitive interface designed for ease of use by both clinical staff and participants. Comprehensive support and training materials are readily available to ensure successful platform adoption.
- User-friendly interface designed for clinical and participant ease.
- On-demand training sessions and extensive support documentation.
- 24/7 customer support to assist with any technical issues.
Innovative Features to Enhance Your Clinical Research
GlucoseReady™ is packed with innovative features that set new standards in clinical research technology. From predictive analytics that forecast patient compliance to automated triggers for eCOA based on specific data thresholds, our platform is designed to advance the field of cardiometabolic disease management.
- Predictive analytics for foreseeing patient adherence issues.
- Automated eCOA triggers based on real-time biomarker data.
- Customizable modules for various therapeutic areas.
Streamlined for your Obesity/Weight Management and NASH/MASH trials
GlucoseReady™ provides modules used separately or together to support multiple therapeutic areas, including within a single GCP platform designed for user-friendliness and the requirements of an FDA inspection.
- Integrated digital platform to capture all data from multiple sources.
- Suite of tools includes disease-specific eCOA, behavioral assessment by the SPUR™ tool, lifestyle standardization, BGM and CGM, digital weight scale and actigraphy.
